Kolling Institute Research Strategy

The Kolling is in a unique position. Established in 1920, it is the oldest medical research institute in New SouthWales, with a rich history of scientific progress and improved patient care. As the Kolling celebrates 100 years of research excellence, it is a good time to map the future direction of the institute and ensure it remains at the forefront of scientific discovery for the next 100 years. A robust strategic framework will strengthen the Kolling’s ability to achieve game-changing research, while delivering new opportunities and greater assistance to our team. The research strategy will focus on areas of strength, positioning the institute as a centre of translational research excellence, improving the health of the broader community. It will provide greater support to researchers, broadening opportunities to directly incorporate scientific discoveries into clinical practice. This will enhance the impact of research across the Kolling and ultimately health outcomes. A collection of research enablers will be instrumental in delivering collaborative opportunities, operational efficiencies and increased funding. Importantly, they will also support the strategic use of resources. A key part of the strategy will see Kolling researchers benefit from the resources and expertise of the joint venture partners, the University of Sydney and the Northern Sydney Local Health District. This will involve targeted support, assisting researchers to make tangible gains. The Kolling Institute Research Strategy has wide-sweeping objectives. • To enhance research outcomes • To increase public and private sector research funding • To strengthen existing partnerships and establish new collaborations • To improve the provision of care and health outcomes locally, nationally and globally • To enhance the Kolling’s reputation for research excellence • To record medical and societal impact across health and industry

The partnership between the Northern Sydney Local Health District and the University of Sydney has been built over a period of 100 years. It will continue long into the future and well beyond both our tenures. The strength of this partnership lies in our shared belief that research is the bedrock on which patient care is built and will be continually improved. It is with this background we now launch the priority research areas that will better leverage our collective expertise, and ultimately deliver on our shared goals. One of our key initiatives is the decision to promote the Kolling as the vehicle for pursuing our translational research priorities as we work together as an unincorporated joint venture. The Faculty of Medicine and Health and Northern Sydney Local Health District have now established the Northern Sydney Precinct unit, to provide dedicated local support for research performance, infrastructure and career development as well as grant management. This will be a unique opportunity to explore new ways of pursuing our long-standing partnership, to deliver for our own communities, and to make our mark on the world stage. It will ensure our research informs patient care and ultimately improves the health of our community. We thank you for your support of the Kolling strategy, and we look forward to our high quality research putting the Kolling in the national and international spotlight.

Deborah Willcox Chief Executive, Northern Sydney Local Health District

Professor Robyn Ward AM Executive Dean,

Pro Vice Chancellor of Medicine and Health, University of Sydney

KOLLING INSTITUTE Research Strategy 2021-2025 3

Made with FlippingBook - professional solution for displaying marketing and sales documents online